Norges Bank Purchases New Holdings in DaVita Inc. (NYSE:DVA)

Norges Bank bought a new position in shares of DaVita Inc. (NYSE:DVA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 48,794 shares of the company's stock, valued at approximately $7,297,000. Norges Bank owned approximately 0.06% of DaVita at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DVA. FMR LLC grew its position in DaVita by 659.9% during the third quarter. FMR LLC now owns 177,406 shares of the company's stock valued at $29,082,000 after buying an additional 154,061 shares during the period. Captrust Financial Advisors lifted its position in DaVita by 16.6% in the 3rd quarter. Captrust Financial Advisors now owns 3,992 shares of the company's stock worth $654,000 after buying an additional 569 shares during the last quarter. Benjamin Edwards Inc. bought a new position in shares of DaVita during the 3rd quarter valued at $207,000. HighTower Advisors LLC grew its position in DaVita by 11.3% during the 3rd quarter. HighTower Advisors LLC now owns 23,335 shares of the company's stock worth $3,813,000 after acquiring an additional 2,376 shares during the last quarter. Finally, Janus Henderson Group PLC increased its position in shares of DaVita by 8.5% in the third quarter. Janus Henderson Group PLC now owns 5,847 shares of the company's stock valued at $958,000 after acquiring an additional 457 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Price Performance

Shares of DaVita stock traded down $6.07 during mid-day trading on Monday, reaching $149.44. 95,157 shares of the stock traded hands, compared to its average volume of 820,898. The business has a 50-day moving average of $152.13 and a 200 day moving average of $156.59. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The stock has a market capitalization of $11.96 billion, a PE ratio of 13.83, a PEG ratio of 1.07 and a beta of 1.04. DaVita Inc. has a fifty-two week low of $125.64 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Analysts Set New Price Targets

DVA has been the topic of a number of research reports. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Cowen restated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. StockNews.com raised DaVita from a "hold" rating to a "buy" rating in a research note on Thursday. Finally, Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, DaVita currently has a consensus rating of "Hold" and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.